Uterine Artery Embolization for Fibroids with and Without Coexistent Adenomyosis: A Large U.S. Commercial Claims Comparative Effectiveness Study.

Mabud TS, Caldwell B, Xiao J, Sarkar D, Reis S, Kang S.

Open source

DOI
10.1016/j.jvir.2026.109187
Published
2026-11-07
Container
J Vasc Interv Radiol
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jvir.2026.109187,
  title = {Uterine Artery Embolization for Fibroids with and Without Coexistent Adenomyosis: A Large U.S. Commercial Claims Comparative Effectiveness Study.},
  author = {Mabud TS and  Caldwell B and  Xiao J and  Sarkar D and  Reis S and  Kang S.},
  year = {2026},
  journal = {J Vasc Interv Radiol},
  doi = {10.1016/j.jvir.2026.109187},
  url = {https://doi.org/10.1016/j.jvir.2026.109187}
}

RIS

TY  - JOUR
TI  - Uterine Artery Embolization for Fibroids with and Without Coexistent Adenomyosis: A Large U.S. Commercial Claims Comparative Effectiveness Study.
AU  - Mabud TS
AU  -  Caldwell B
AU  -  Xiao J
AU  -  Sarkar D
AU  -  Reis S
AU  -  Kang S.
PY  - 2026
JO  - J Vasc Interv Radiol
DO  - 10.1016/j.jvir.2026.109187
UR  - https://doi.org/10.1016/j.jvir.2026.109187
ER  - 

APA

TS, M., B, C., J, X., D, S., S, R., & S., K. (2026). Uterine Artery Embolization for Fibroids with and Without Coexistent Adenomyosis: A Large U.S. Commercial Claims Comparative Effectiveness Study.. J Vasc Interv Radiol. https://doi.org/10.1016/j.jvir.2026.109187

Source records